Clinical Trials in France

• Phase 3 Study of ALXN1850 in Pediatric Participants with HPP Previously Treated with Asfotase Alfa Revoked
  2023-505674-15-00 Phase III Hypophosphatasia Alexion Pharmaceuticals Inc.
• ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Not authorised
  2022-500535-36-00 Phase III Moderately to severely active ulcerative colitis Abivax
• ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Not authorised
  2022-500536-11-00 Phase III Moderately to severely active ulcerative colitis Abivax
• ABTECT-Maintenance – ABX464 Treatment Evaluation for ulcerative Colitis Therapy Not authorised
  2022-500537-84-00 Phase III Moderately to severely active ulcerative colitis Abivax
• A phase II study evaluating the efficacy and safety of IMetelstat in Patients with HR myElodysplastic SyndromeS or AML failing HMA-based the… Not authorised
  2022-500721-32-00 Phase II AML and MDS patients failing or being refractory to hypometh… Gcp-Service International West GmbH
• Clinical trial of MK-7648A in adults and children with skin cancer Not authorised
  2022-501417-31-00 Phase III High-risk Resected Melanoma Merck Sharp & Dohme LLC
• Early detection of triple negative breast cancer relapse (CUPCAKE) Not authorised
  2022-501562-22-00 Phase II Triple-negative breast cancer (TNBC) patients at high risk o… Institut Curie
• A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised
  2022-501644-15-00 Phase II Mild Cognitive Impairment due to Alzheimer's Disease Alzheim… Biogen Idec Research Limited
• A Phase IIIb, Single Arm, Open-label, Multicentre Study of Durvalumab in Combination with Chemotherapy for the First Line Treatment for Pati… Not authorised
  2022-502043-35-00 Phase III Advanced Biliary Tract Cancers AstraZeneca AB
• A clinical study of people with HIV‐1 who switch their treatment to a combination of doravirine and islatravir​​ Not authorised
  2022-502079-49-00 Phase III HIV-1 infection Merck Sharp & Dohme LLC
• A clinical study of people with HIV-1 who have not taken antiretroviral therapy, one group will start treatment with a combination of doravi… Not authorised
  2022-502099-22-00 Phase III HIV-1 Infection Merck Sharp & Dohme LLC
• A clinical study of people with HIV-1 who received prior treatment combination of doravirine and islatravir Not authorised
  2022-502126-40-00 Phase III HIV-1 infection Merck Sharp & Dohme LLC
• A clinical study of people with HIV-1 who take antiretroviral therapy and switch their treatment to a combination of doravirine and islatrav… Not authorised
  2022-502127-22-00 Phase III HIV-1 Infection Merck Sharp & Dohme LLC
• A Phase I Study of RO7589831 in Participants with Advanced Solid Tumors Not authorised
  2023-503170-20-00 Phase I Advanced solid tumors F. Hoffmann-La Roche AG
• Baricitinib for treating hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype, an international phase II … Not authorised
  2023-503480-42-00 Phase II/III Hospital-acquired pneumonia Centre Hospitalier Universitaire De Nantes
• HARMONi-3 Not authorised
  2023-504989-37-00 Phase III Metastatic Squamous Non-small Cell Lung Cancer Summit Therapeutics Sub Inc.
• A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR) - targeting, Bif… Not authorised
  2023-505334-10-00 Phase I (FiH) Unresectable, Locally Advanced, or Metastatic Solid Tumors Marengo Therapeutics Inc.
• Randomized, double-blind, Placebo-controlled, 2x2 cross over study assessing the efficacy and safety of cANnabidiol oral solution for joint … Not authorised
  2023-505380-36-00 Phase III Patients with stage I, II, III hormone-receptor positive (HR… Institut Gustave Roussy
• Safety, tolerability, and efficacy of mFOLFIRINOX ±BNT321 as adjuvant therapy following curative resection in patients with pancreatic adeno… Not authorised
  2023-506014-47-00 Phase I/II Resected (R0 or R1) pancreatic ductal adenocarcinoma BioNTech SE
• A study to assess the efficacy and safety of OATD-01 for the treatment of active pulmonary sarcoidosis. Not authorised
  2023-506642-23-00 Phase II Active Pulmonary Sarcoidosis Molecure S.A.
• MAMI Use of the Methoxyflurane as pain-killer in the prehospital management of Acute Myocardial Infarction Not authorised
  2023-507296-21-00 Phase III Acute Myocardial Infarction Assistance Publique Hopitaux De Paris
• A Study Providing Continued Access to Treatment in Patients with a Neurological Disease Previously Enrolled in a Genentech and/or F. Hoffman… Not authorised
  2023-507633-21-00 Phase III Neurological Disease F. Hoffmann-La Roche AG
• ExplOratory, Phase 0 Study to assess biodisTribution and PosItron EMission Tomography (PET) Imaging kinetics of [64Cu]Cu-PSMA-R2 in metaStat… Not authorised
  2023-508473-86-00 Phase I (Other) metastatic prostate cancer Institut De Cancerologie De L Ouest
• Clinical trial to assess the safety and tolerability of TP-122A for the treatment of ventilator-associated pneumonia. Not authorised
  2023-508825-29-00 Phase I (FiH) Ventilator-Associated Pneumonia Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A.

Showing 1–24 of 4,419 trials